Results 151 to 160 of about 35,059 (247)
Total arch replacement as treatment for repeated cerebral infarctions due to unstable plaque simultaneously in the innominate artery and left subclavian artery: a case report. [PDF]
Nakanishi S +7 more
europepmc +1 more source
In adults aged 40−70 years, body fat percentage, waist‐to‐height ratio, and waist‐to‐hip ratio were the strongest correlates of elevated 10‐year ASCVD risk, while fat‐free mass showed an inverse association. In younger adults, central adiposity and body fat measures were most strongly associated with higher ASCVD risk.
Mohammad Javad Zibaeenezhad +16 more
wiley +1 more source
A systematic review and meta‐analysis of 9 randomised controlled trials (67,662 patients) found that evolocumab significantly improved lipid parameters and reduced major adverse cardiovascular events, myocardial infarction, and coronary revascularisation.
Anika Goel +10 more
wiley +1 more source
Dual-Omics Profiling of Carotid Plaques Reveals Stage-Dependent Host-Microbiome Interaction Dynamics from Formation to Rupture. [PDF]
Zhou S +6 more
europepmc +1 more source
From Calcium Volume Correlations to Whole-Plaque Phenotyping: A Road Still to Be Traveled. [PDF]
Papazoglou AS, Tsiartas E, Tagarakis GI.
europepmc +1 more source
ABSTRACT Studies have shown that omega‐3 fatty acids may protect against cardiovascular diseases (CVDs) and related metabolic conditions. UK Biobank is a large cohort study that includes data on plasma omega‐3 fatty acids at study entry and health outcomes during the follow‐up period.
Warda Tul Firdous, Philip C. Calder
wiley +1 more source
Molecular Mapping of Atherosclerotic Plaques with MALDI Mass Spectrometry Imaging. [PDF]
Leksa D +8 more
europepmc +1 more source
Susceptibility to unstable atherosclerotic plaques
openaire +1 more source
Neurodegenerative diseases share convergent risk architectures and pathological mechanisms, yet diverge in selective vulnerability, clinical presentation, and therapeutic responsiveness. This review integrates cross‐disease epidemiology, pathophysiology, diagnosis, and treatment, highlighting the transition from symptomatic care toward biomarker‐guided
Zimeng He +4 more
wiley +1 more source
Alzheimer's Disease: Mechanisms and Therapeutic Advances
Alzheimer's disease involves Aβ/tau aggregation, neuroinflammation, BBB leakage, gut–brain dysfunction, and mitochondrial damage, causing neuronal loss. Nanodelivery enables combined small‐molecule and targeted therapies. Disease‐modifying biologics/chemicals, including anti‐Aβ antibodies, raise safety and access concerns. Exercise, cognitive training,
Gaoshuang Fu +4 more
wiley +1 more source

